Lipid lowering in post-Mi patients with normal cholesterol
Lawless, C.; Force, R.
Journal of Family Practice 44(1): 30
1997
ISSN/ISBN: 0094-3509 PMID: 9010366 Document Number: 470893
Document emailed within 1 workday
Related Documents
Praipaisarnkit, K.; Wongpraparut, N.; Pongakasira, R. 2014: Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic Journal of the Medical Association of Thailand 97(Suppl 3): S147-S154Pearson, T.A.; Laurora, I.; Chu, H.; Kafonek, S. 2000: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Archives of Internal Medicine 160(4): 459-467
Leitersdorf, E. 2002: Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management International Journal of Clinical Practice 56(2): 116-119
Ali, F.; Laurin, M.-Y.; Larivière, C.; Tremblay, D.; Cloutier, D. 2003: The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels Canadian Journal of Clinical Pharmacology 10(3): 101-106
Marmo, E.; Caputi, A.P.; Vacca, C.; Imperatore, A.; Cataldi, S. 1974: Cholesterol and lipid lowering effects and vascular action of p-chlororphenoxy-alpha-isobutyrate of 3-hydroxymethyl-pyridine-hydrochloric acid (clofinol) La Clinica Terapeutica 68(6): 519-567
2015: Switching from high-efficacy lipid-lowering therapies [atorvastatin or rosuvastatin] to simvastatin and the results on low-density lipoprotein cholesterol level Journal of the Medical Association of Thailand 98(1): 21-25
Augusti, K.T. 1974: Lipid lowering effect of allyl propyl disulphide isolated from Allium cepa Linn. on long term feeding to normal rats Indian Journal of Biochemistry and Biophysics 11(3): 264-265
Gialamas, A.; Aylward, P.; Vanlint, S.; Stocks, N.P. 2011: Cholesterol lowering medication - patients' knowledge, attitudes and experiences Australian Family Physician 40(7): 519-522
2005: Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source MMW Fortschritte der Medizin 147(23): 48-49
Hoppichler, F.; Lechleitner, M.; Patsch, J.R. 1992: Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(11): 523-527
Moyad, M.A.; Merrick, G.S. 2006: Cholesterol, cholesterol lowering agents/statins, and urologic disease: part i - knowing your numbers Urologic Nursing 26(2): 156-159
Grundy, S.M.; Cleeman, J.I.; Rifkind, B.M.; Kuller, L.H. 1999: Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program Archives of Internal Medicine 159(15): 1670-1678
Stoy, N. 1997: Influence of cholesterol on survival after stroke. Beneficial effects of cholesterol lowering on atherosclerosis may not lessen with age Bmj 315(7116): 1158; Author Reply 1159
Bates, M.C.; Warren, S.G.; Grubb, S.; Chillag, S. 1990: Effectiveness of low-dose lovastatin in lowering serum cholesterol. Experience with 56 patients Archives of Internal Medicine 150(9): 1947-1950
Miskić, B.; Bistrović, D.; Cosić, V.; Leko, N.; Balen-Jandrić, M.; Balen, I.; Samardzić, P.; Miskić, D. 2003: Effect of raloxifene on lowering lipid parameters in patients with osteoporosis International Journal of Clinical Pharmacology Research 23(4): 107-110
Westendorp, R.G.; Smelt, A.H. 1996: Cholesterol synthesis inhibitors: lowering of cholesterol for everybody? Nederlands Tijdschrift Voor Geneeskunde 140(8): 411-414
Sukonthasarn, A.; Homsanit, M.; Prommete, B.; Chotinaiwattarakul, C.; Piamsomboon, C.; Likittanasombat, K. 2011: Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey Journal of the Medical Association of Thailand 94(12): 1424-1434
Kokot, F.; Szczechowska, E. 1981: Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(13): 454-457
Supanich, B. 1999: Aggressive lipid-lowering in stable patients with coronary artery disease Journal of Family Practice 48(10): 749-750
Shirai, K.; Matsuoka, N.; Morisaki, N.; Murano, S.; Sasaki, N.; Shinomiya, M.; Saito, Y.; Kumagai, A.; Mizobuchi, M. 1980: Effects of tocopherol deficiency on lipid metabolism in the arterial wall of rats on normal and high cholesterol diets Artery 6(6): 484-506